MMP2 and pancreatic neoplasm: FOXM1 was shown to stimulate angiogenesis in several cancers, including pancreatic cancer, gastric cancer and glioma, through induction of vascular endothelial growth factor (VEGF), matrix metalloproteinase-2 (MMP-2) and MMP-9 [13–15].